CP and cancer: After these findings, different forms of d/n ATF5, such as cell-penetrating d/n-ATF5-recombinant peptide (CP-d/n-ATF5-RP) and cell-penetrating d/n-ATF5-synthesized peptide (CP-d/n-ATF5-S1), were designed and investigated in various cancer types with promising results.